Gregory Schiffman

Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.

VNUS Medical Technologies, Inc. provides medical devices and procedures for the minimally invasive treatment of venous reflux disease, an underlying cause of varicose veins. Venous reflux disease results in symptoms such as leg pain, swelling, fatigue, skin ulcers, and painful varicose veins. The company was founded on January 31, 1995 and is headquartered in San Jose, CA.

Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA.

IMPAC Medical Systems, Inc. develops integrated software for oncology. It provides integrated clinical and administrative management systems for cancer specialists. The company was founded by Joseph K. Jachinowski, James P. Hoey and David A. Auerbach in January 1990 and is headquartered in Sunnyvale, CA.

Nanomix, Inc. provides nano technology solutions. It is a nanotechnology company focused on development of next generation Point of Care diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings. The firm's nanoscale electronic sensors have enabled the development of the next generation of Point of Care testing systems that can be used in any setting. The company's mobile diagnostic platform performs multiple in-vitro diagnostic assays simultaneously from a single whole-blood sample. Nanomix was founded by Alexander Zettl and Marvin L. Cohen in September 2000 and is headquartered in Emeryville, CA.

Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA.

Hewlett-Packard France SAS provides computing and imaging solutions. The company provides a range of consumer and professional technology products to the corporate customers and retailers. Its products include personal computers, servers, data storage devices, printing and imaging equipment and enterprise software. It also offers IT services including consulting, product integration and support. The company is headquartered in Les Ulis, France.

Vineti, Inc. develops software for scaling and digital solutions for cell and gene therapies. The firm focuses on enabling life changing autologous therapies, supporting standards, and developing infrastructure that will expand patient access through expedited discovery, delivery and regulation in the field. The company was founded by Heidi Hagen, Malek Faham, Amy DuRoss and Razmik Abnous and is headquartered in San Francisco CA.

DropCar, Inc. operates as a cloud-based vehicle support platform and mobile app. It helps consumers and automotive-related companies reduce the cost, hassles and inefficiencies of owning a car, or fleet of cars, in urban centers. The company was founded by Michael Spencer Richardson and David Brian Newman in September 2014 and is headquartered in New York, NY.

BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA.

Mirror Biologics Inc manufactures immune modulatory vaccines and therapeutics. The company is based in Tampa, FL. The company was founded in 2019 by Michael Har-Noy. Michael Har-Noy has been the CEO since 2019.